Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

BIA

Biotech threatened by UK drug pricing changes, says BIA

It says VBP will undermine the attractiveness of the sector for investors

ABPI London offices

ABPI toolkit to help pharma companies disclose trial data

Aims to improve transparency efforts in UK

- PMLiVE

UCB’s Steve Arnold joins ABPI board

Will work to support life sciences in the UK

- PMLiVE

Edward Hodgkin elected chair of UK biotech association

He will take up his new role at the BIA in October

- PMLiVE

ABPI appoints new director of comms

Catherine Meaden was previously head of policy and public affairs at the body

- PMLiVE

England to launch 15 networks for NHS to work with academia

NHS England backs Academic Health Science Networks to spread innovation

ABPI London offices

ABPI: Pharma must sell outcomes, not products

Annual conference told industry must re-establish its social contract with the NHS

- PMLiVE

BMS and Vertex partner on oral hepatitis treatment

Will investigate combination of daclatasvir and VX-135

ABPI publishes updated guidance on pharmacovigilance and digital media

In a guest blog, the ABPI's Esteban Herrero-Martinez explains what changes to European pharmacovigilance legislation mean for ABPI members

- PMLiVE

Pharmaceutical conference to discuss healthcare in the new NHS

ABPI’s chief executive calls for “bold, provocative ideas” in new UK healthcare landscape

ABPI London offices

Pharma paid UK healthcare professionals £40m in 2012

Payments published as part of ABPI drive towards greater industry transparency

Interview: Steve Bates, BIA

The CEO of the BioIndustry Association discusses the state of UK biotech, its shared ecosystem with pharma and the funding challenges biotech faces

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links